Ameriprise Financial Inc. Sells 1,454 Shares of Chemed Co. (NYSE:CHE)

Ameriprise Financial Inc. lowered its position in Chemed Co. (NYSE:CHE - Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 233,651 shares of the company's stock after selling 1,454 shares during the quarter. Ameriprise Financial Inc. owned about 1.55% of Chemed worth $123,809,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in CHE. Algert Global LLC grew its position in Chemed by 1.2% in the 4th quarter. Algert Global LLC now owns 23,375 shares of the company's stock valued at $12,384,000 after buying an additional 275 shares in the last quarter. Aptus Capital Advisors LLC boosted its holdings in shares of Chemed by 22.0% in the fourth quarter. Aptus Capital Advisors LLC now owns 40,695 shares of the company's stock valued at $21,561,000 after acquiring an additional 7,327 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Chemed by 112.9% in the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 10,460 shares of the company's stock valued at $5,542,000 after acquiring an additional 5,548 shares in the last quarter. Freestone Grove Partners LP acquired a new position in shares of Chemed during the fourth quarter valued at approximately $61,664,000. Finally, Voleon Capital Management LP bought a new stake in Chemed during the fourth quarter worth approximately $1,136,000. Institutional investors own 95.85% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CHE. Royal Bank of Canada upped their price target on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Price Performance

CHE traded up $3.85 during trading on Friday, reaching $572.90. 75,062 shares of the stock traded hands, compared to its average volume of 100,480. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $623.61. The stock's 50-day simple moving average is $589.27 and its two-hundred day simple moving average is $565.09. The stock has a market cap of $8.38 billion, a price-to-earnings ratio of 28.95, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company's revenue for the quarter was up 9.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.20 EPS. Research analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio (DPR) is currently 9.74%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Spencer S. Lee sold 1,500 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total value of $866,790.00. Following the completion of the sale, the executive vice president now owns 16,127 shares of the company's stock, valued at $9,319,148.22. This represents a 8.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,000 shares of company stock valued at $3,534,135 in the last three months. Company insiders own 3.29% of the company's stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.